NO953689D0 - Serumantioksidanter som indikatorer på voksenåndenödsyndrom hos septiske pasienter - Google Patents

Serumantioksidanter som indikatorer på voksenåndenödsyndrom hos septiske pasienter

Info

Publication number
NO953689D0
NO953689D0 NO953689A NO953689A NO953689D0 NO 953689 D0 NO953689 D0 NO 953689D0 NO 953689 A NO953689 A NO 953689A NO 953689 A NO953689 A NO 953689A NO 953689 D0 NO953689 D0 NO 953689D0
Authority
NO
Norway
Prior art keywords
respiratory distress
distress syndrome
adult respiratory
indicators
septic patients
Prior art date
Application number
NO953689A
Other languages
English (en)
Norwegian (no)
Inventor
John E Repine
Jonathan A Leff
Original Assignee
John E Repine
Jonathan A Leff
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by John E Repine, Jonathan A Leff filed Critical John E Repine
Publication of NO953689D0 publication Critical patent/NO953689D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/30—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving catalase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96447—Factor VII (3.4.21.21)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Neurosurgery (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO953689A 1993-03-19 1995-09-19 Serumantioksidanter som indikatorer på voksenåndenödsyndrom hos septiske pasienter NO953689D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/034,935 US5389522A (en) 1993-03-19 1993-03-19 Serum antioxidants as predictors of the adult respiratory distress syndrome in septic patients
PCT/US1994/002925 WO1994022016A1 (fr) 1993-03-19 1994-03-18 Antioxydants seriques utilises en tant que predicteurs du syndrome de detresse respiratoire aigue de l'adulte

Publications (1)

Publication Number Publication Date
NO953689D0 true NO953689D0 (no) 1995-09-19

Family

ID=21879562

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953689A NO953689D0 (no) 1993-03-19 1995-09-19 Serumantioksidanter som indikatorer på voksenåndenödsyndrom hos septiske pasienter

Country Status (9)

Country Link
US (2) US5389522A (fr)
EP (2) EP0757105A3 (fr)
JP (1) JPH08511864A (fr)
AT (1) ATE159102T1 (fr)
AU (1) AU690106B2 (fr)
CA (1) CA2158579C (fr)
DE (1) DE69406115T2 (fr)
NO (1) NO953689D0 (fr)
WO (1) WO1994022016A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5389522A (en) * 1993-03-19 1995-02-14 Repine; John E. Serum antioxidants as predictors of the adult respiratory distress syndrome in septic patients
US5504111A (en) * 1994-12-30 1996-04-02 Medichem Research, Inc. Use of 2,3 alkylcarbonyloxybenzoic acid in treating adult respiratory distress syndrome
US5679532A (en) * 1995-12-13 1997-10-21 University Technology Corporation Serum ferritin as a predictor of the acute respiratory distress syndrome
MXPA05005073A (es) * 2002-11-12 2005-11-17 Becton Dickinson Co Diagnostico de la sepsis o sirs usando perfiles de biomarcadores.
EP1562046A1 (fr) * 2004-02-03 2005-08-10 B.R.A.H.M.S Aktiengesellschaft Procede pour le diagnostic de la septicemie par detection selective de la concentration de la superoxide dismutase 1 dans des echantillions biologiques
US7998698B2 (en) * 2006-05-31 2011-08-16 Health Research Inc. Method for predicting susceptibility to radiation pneumonitis
JP5715636B2 (ja) * 2009-11-03 2015-05-13 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 循環系事象と虚血性事象を鑑別するためのＮＴ−ｐｒｏＡＮＰおよびＳＦｌｔ−１
SE535502C2 (sv) * 2010-09-14 2012-08-28 Calmark Sweden Ab System och metod för att analysera risk eller förekomst av organsvikt
WO2022234101A1 (fr) * 2021-05-06 2022-11-10 Jazz Pharmaceuticals Ireland Limited Défibrotide pour le traitement et la prévention du syndrome de détresse respiratoire aiguë

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3926732A (en) * 1973-02-16 1975-12-16 Alfa Laval Ab Method for assaying catalase in milk and other liquids
US5147783A (en) * 1988-05-27 1992-09-15 Ube Industries, Ltd. Methods to screen for ovarian cancer and myocardial infarction
US5389522A (en) * 1993-03-19 1995-02-14 Repine; John E. Serum antioxidants as predictors of the adult respiratory distress syndrome in septic patients

Also Published As

Publication number Publication date
ATE159102T1 (de) 1997-10-15
AU690106B2 (en) 1998-04-23
AU6448194A (en) 1994-10-11
EP0689674A1 (fr) 1996-01-03
EP0757105A3 (fr) 1998-01-28
JPH08511864A (ja) 1996-12-10
DE69406115D1 (de) 1997-11-13
CA2158579C (fr) 1999-01-26
US5639629A (en) 1997-06-17
EP0689674B1 (fr) 1997-10-08
US5389522A (en) 1995-02-14
EP0757105A2 (fr) 1997-02-05
WO1994022016A1 (fr) 1994-09-29
DE69406115T2 (de) 1998-04-30
CA2158579A1 (fr) 1994-09-29

Similar Documents

Publication Publication Date Title
Woodward et al. Trial of an intervention to reduce passive smoking in infancy
EP1503213A3 (fr) Detection et determination des stades d'une maladie des arteres coronaires
NO975319D0 (no) System for måling av oksygennivå i blod
NO953689D0 (no) Serumantioksidanter som indikatorer på voksenåndenödsyndrom hos septiske pasienter
DE3879207D1 (de) Ein automatisches system zur pflege bettlaegeriger patienten.
DE69510336T2 (de) Verfahren zur diagnose von praeklampsie
NO20020043D0 (no) Fremgangsmåte og system for anvendelse ved behandling av en pasient med et hvilket som helst medikament for å optimalisereterapi og forhindre en negativ medikament respons
DE69204157D1 (de) Verfahren zur bestimmung von anti-rns-antikörpern.
Blood et al. Elementary school-aged stutterers' disfluencies during oral reading and spontaneous speech
AU5336796A (en) Method for detecting allergy
ES2099876T3 (es) Procedimiento para la determinacion de anticuerpos de lupus anticoagulante que provocan trombosis.
SE9401975D0 (sv) The use of sialic acid determinations
EP0778027A3 (fr) Utilisation de silice pour la préparation de médicaments
O’Connor et al. The efficacy and safety profile of a new antipsychotic, ziprasidone
DE69019431D1 (de) Verwendung von 15-Keto-Prostansäure-Derivaten zur Herstellung eines Medikaments für die Verbesserung der Ausscheidung des Kaliumions.
Boath et al. Social adjustment in childbearing women: the modified Work Leisure and Family Life Questionnaire
Fernando et al. Lead in Bone and Hypertension
RU97119387A (ru) Способ оценки функционального состояния циркулирующих нейтрофилов у человека
Pearlman Late luteal phase dysphoric disorder and DSM-III-R
Freudenberg et al. Depression and laterality of lesion in brain injured adults
SHIBATA et al. Studies on intraglomerular coagulation (II)
Delgado et al. The relationship between immunological function and stress among schizophrenic patients
IW An automated method for the measurement of oxygen consumption and carbon dioxide excretion in man
DK16995A (da) Middel til analyse af fysiologisk dannet HCG's eliminering hos en human patient, fremgangsmåde til en vitro-måling af HCG-omsætning i patienter med forhøjet HCG-niveau samt anvendelse af et sådant middel
RU93001215A (ru) Способ определения показаний к лечению гемоспленоперфузией при гнойном перитоните